![](https://m.media-amazon.com/images/M/MV5BY2NiYjhjODgtYWZjNi00NTEwLWE3ZWMtMjQ5Mzk0YTA5MDU4XkEyXkFqcGdeQXVyNjg1NzA4ODY@._V1_SY139_CR3,0,92,139_.jpg)
Dying to Survive
The story of how a small drugstore owner became the exclusive selling agent of a cheap Indian generic drug against Chronic Granulocytic Leukemia in China.
Rollout
–
$451,176,639
$451,176,639
China | |||
---|---|---|---|
Market | Release Date | Opening | Gross |
China | Jul 5, 2018 | $152,163,428 | $451,176,639 |